Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,063 | 2 | 94.6% |
| Unspecified | $476.50 | 2 | 3.2% |
| Food and Beverage | $325.20 | 5 | 2.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | $8,820 | 1 | $0 (2024) |
| SANOFI US SERVICES INC. | $5,443 | 2 | $0 (2018) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $524.64 | 5 | $0 (2022) |
| Celgene Corporation | $77.45 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,820 | 1 | VERTEX PHARMACEUTICALS INCORPORATED ($8,820) |
| 2022 | $190.00 | 1 | NOVARTIS PHARMACEUTICALS CORPORATION ($190.00) |
| 2019 | $304.53 | 2 | Novartis Pharmaceuticals Corporation ($304.53) |
| 2018 | $5,550 | 5 | SANOFI US SERVICES INC. ($5,443) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Consulting Fee | Cash or cash equivalent | $8,820.00 | General |
| 08/02/2022 | NOVARTIS PHARMACEUTICALS CORPORATION | PROMACTA (Drug) | — | In-kind items and services | $190.00 | Research |
| Study: PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH HEOR RESEARCH • Category: ONCOLOGY | ||||||
| 06/04/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/01/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | PROMACTA (Drug) | — | In-kind items and services | $286.50 | Research |
| Study: RESEARCH RELATED PUBLICATIONS SUPPORT • Category: ONCOLOGY | ||||||
| 11/06/2018 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Consulting Fee | Cash or cash equivalent | $5,243.00 | General |
| 11/06/2018 | SANOFI US SERVICES INC. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $199.61 | General |
| 10/10/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $77.45 | General |
| 05/22/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/08/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: CARDIOVASCULAR | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATIONS SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $286.50 | 1 |
| PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH HEOR RESEARCH | NOVARTIS PHARMACEUTICALS CORPORATION | $190.00 | 1 |
About Dr. David Williams, MD
Dr. David Williams, MD is a Pediatric Hematology-Oncology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871658682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Williams, MD has received a total of $14,865 in payments from pharmaceutical and medical device companies, with $8,820 received in 2024. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($14,063).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Boston, MA
- Active Since 12/22/2006
- Last Updated 05/13/2009
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1871658682
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $5,443
- PROMACTA (Drug) $476.50
- ENTRESTO (Drug) $48.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Boston
Mr. Alan Dandrea, Md, MD
Pediatric Hematology-Oncology — Payments: $826,972
Dr. Leslie Kean, Md/Phd, MD/PHD
Pediatric Hematology-Oncology — Payments: $326,453
Todd Golub, M.d, M.D
Pediatric Hematology-Oncology — Payments: $247,953
Dr. Stacy Croteau, Md, MD
Pediatric Hematology-Oncology — Payments: $219,942
Matthew Heeney, Md, MD
Pediatric Hematology-Oncology — Payments: $201,707
Christine Duncan, M.d, M.D
Pediatric Hematology-Oncology — Payments: $74,023